Literature DB >> 2102623

Nucleotide sequences of the three genes coding for human fibrinogen.

D W Chung1, J E Harris, E W Davie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2102623     DOI： 10.1007/978-1-4615-3806-6_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  10 in total

1.  Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller.

Authors:  Ramesh B Basani; Hua Zhu; Michael A Thornton; Cinque S Soto; William F Degrado; M Anna Kowalska; Joel S Bennett; Mortimer Poncz
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

2.  Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).

Authors:  S O Brennan; B Hammonds; P M George
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 3.  Fibrin Formation, Structure and Properties.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Subcell Biochem       Date:  2017

4.  Genetic Modulation of Plasma Fibrinogen Concentrations: Possible Importance of Interleukin-6.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

5.  Frequency distribution of the G/A alleles of the beta-fibrinogen gene in the Lebanese population.

Authors:  Dina M R Shammaa; Amira S Sabbagh; Ali T Taher; Ghazi S Zaatari; Rami A R Mahfouz
Journal:  Mol Biol Rep       Date:  2007-05-12       Impact factor: 2.316

6.  Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes as the major site of synthesis and assignment of the gene to chromosome 9.

Authors:  J Lu; P N Tay; O L Kon; K B Reid
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

7.  Use of purified fibrinogen concentrate for dysfibrinogenemia and importance of laboratory fibrinogen activity measurement.

Authors:  Emily B Franzblau; Rowena C Punzalan; Kenneth D Friedman; Angshumoy Roy; Ozlem Bilen; Veronica H Flood
Journal:  Pediatr Blood Cancer       Date:  2012-11-05       Impact factor: 3.167

8.  Hereditary renal amyloidosis with a novel variant fibrinogen.

Authors:  T Uemichi; J J Liepnieks; M D Benson
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

Review 9.  Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis.

Authors:  Vassilios P Memtsas; Deepa R J Arachchillage; Diana A Gorog
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

Review 10.  Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective.

Authors:  Fanny Risser; Ivan Urosev; Joanan López-Morales; Yang Sun; Michael A Nash
Journal:  Biophys Rev       Date:  2022-04-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.